Gold Standard Diagnostics Frankfurt GmbH is a leading healthcare provider of diagnostic solutions with extensive experience in the clinical market. The company provides automated platforms and a broad menu of tests in the fields of virology, bacteriology, parasitology, mycology, hormones, autoimmune diseases, and more recently, in oncology.

On the oncology field, we offer the M371-Test for the diagnosis and follow-up monitoring of testicular germ cell tumors (TGCT); a faster, substantially more precise, and reliable solution than current biomarker standards.

We are fully committed to enhancing patient care by dedicating our efforts to innovative development, quality manufacturing, and outstanding commercialization of diagnostic solutions throughout our global network of partners.